
China’s National Medical Products Administration (NMPA) has given the green light to Shanghai’s Henlius for its biosimilar version of Roche’s …

The Chinese Centre for Drug Evaluation (CCDE) has said that coronavirus vaccines must show 50 percent efficacy to be approved. …

China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …

Eli Lilly Shanghai, an affiliate of the wider company, has enlisted the help of biopharma firm Hutchinson China MediTech, or …

China’s National Medical Products Administration (NMPA) has moved to approve a 300mg pre-filled pen formulation of Sanofi and Regeneron’s Dupixent …

Scott Morrison, the Australian Prime Minister, has called for an investigation into the origins of the COVID-19 coronavirus, as Australia …

National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European …

The FDA have announced they will allow doctors to use convalescent plasma, collected from people who recovered from COVID-19, to …

Gilead Sciences has submitted a request for the FDA to rescind its offer of Orphan Drug designation for remdesivir in …

China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …

Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …

The coronavirus continues to dominate the news, with the disease finally getting treated. In America, a patient has been successfully …

The coronavirus outbreak reached its deadliest day since it began in December. Roughly 242 deaths have been reported in Hubei …

A third British person has been diagnosed with the coronavirus, which he allegedly caught in Singapore.He was tested in Brighton …